Cite
Effect of Pro Re Nata Regimen with Anti-VEGF on Type 3 Macular Neovascularization: Long-Term Outcomes.
MLA
Toto, Lisa, et al. “Effect of Pro Re Nata Regimen with Anti-VEGF on Type 3 Macular Neovascularization: Long-Term Outcomes.” Ophthalmic Research, vol. 67, no. 1, Jan. 2024, pp. 282–91. EBSCOhost, https://doi.org/10.1159/000538441.
APA
Toto, L., Viggiano, P., Quarta, A., Grassi, M., De Nicola, C., Aloia, R., D’Aloisio, R., Boscia, G., Boscia, F., Porreca, A., Di Nicola, M., Savastano, M. C., & Mastropasqua, R. (2024). Effect of Pro Re Nata Regimen with Anti-VEGF on Type 3 Macular Neovascularization: Long-Term Outcomes. Ophthalmic Research, 67(1), 282–291. https://doi.org/10.1159/000538441
Chicago
Toto, Lisa, Pasquale Viggiano, Alberto Quarta, Mariaoliva Grassi, Chiara De Nicola, Raffaella Aloia, Rossella D’Aloisio, et al. 2024. “Effect of Pro Re Nata Regimen with Anti-VEGF on Type 3 Macular Neovascularization: Long-Term Outcomes.” Ophthalmic Research 67 (1): 282–91. doi:10.1159/000538441.